←Back to Expert Scholars
Translational Medicine / 转化医学KRAS Inhibitors, Early Phase Trials
Adrian Sacher
MD
🏢Princess Margaret Cancer Centre🌐Canada
Assistant Professor and Clinician Scientist
35
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Adrian Sacher leads early-phase trials of KRAS inhibitors at Princess Margaret and studies immune features of KRAS-mutant NSCLC. His work informs rational combinations with checkpoint inhibitors. He contributes to Canadian lung cancer consortia.
Share:
🧪Research Fields 研究领域
NSCLC
KRAS G12C
early phase trials
immunotherapy combinations
thoracic oncology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Adrian Sacher 的研究动态
Follow Adrian Sacher's research updates
留下邮箱，当我们发布与 Adrian Sacher（Princess Margaret Cancer Centre）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment